Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 137.20
-2.20 (-1.58%)
Oct 10, 2025, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 2.28 billion as of October 10, 2025. Its market cap has increased by 4.22% in one year.
Market Cap
2.28B
Enterprise Value
2.24B
Revenue
235.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
137.20
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 2.28B, an increase of 69.03%. That is a compound annual growth rate of 14.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 2.28B | 16.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 105.98B |
| Sectra AB | 58.76B |
| Getinge AB | 57.22B |
| Camurus AB | 41.49B |
| Medicover AB | 39.56B |
| Asker Healthcare Group AB | 33.44B |
| BioArctic AB | 26.56B |
| AddLife AB | 22.67B |